Skip to main content
Medical information Clinical review pending

Immunology Testing

Endomysial Antibody IgA IFA Test

The Endomysial Antibody IgA IFA Test helps diagnose celiac disease by detecting specific antibodies in the blood. It is used for individuals with gastrointestinal symptoms.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
2 mL (1 mL minimum) serum from 1 Serum Separator Tube (SST).
Results
Results are typically available on the same day if the sample is submitted by 11 am. Confirm with the laboratory before booking.
Preparation
Overnight fasting is recommended. Confirm specific requirements with the laboratory before booking.
Test priceKSh 3,978

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Endomysial Antibody IgA IFA Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Suspected celiac disease
  • ✓Chronic diarrhea
  • ✓Abdominal pain and bloating
  • ✓Unexplained weight loss
  • ✓Family history of celiac disease
  • ✓Monitoring response to gluten-free diet
02

In plain language

What this test helps you understand

This test is primarily used to aid in the diagnosis of celiac disease, an autoimmune disorder triggered by gluten.
The Endomysial Antibody IgA IFA Test is a diagnostic tool used to detect antibodies against endomysium, a connective tissue found in the gastrointestinal tract. This test is particularly useful for individuals suspected of having celiac disease, an autoimmune disorder triggered by gluten ingestion, which damages the small intestine.

This test measures the presence of IgA antibodies targeting endomysial tissue. A positive result suggests an autoimmune response, often linked to celiac disease. The Immunofluorescence Assay (IFA) method employed offers high sensitivity and specificity for accurate diagnosis.

Individuals experiencing persistent symptoms like chronic diarrhea, abdominal pain, bloating, or unexplained weight loss may benefit from this test. People with a family history of celiac disease or related autoimmune conditions are also encouraged to consider testing.

Early detection of celiac disease allows for appropriate dietary management and symptom control. This test can guide necessary lifestyle changes and help monitor treatment effectiveness.

Results are typically available on the same day, facilitating prompt diagnosis and management. A positive result indicates the presence of endomysial antibodies and warrants further medical evaluation. Discuss your results with your healthcare provider for accurate interpretation and guidance.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationOvernight fasting is recommended. Confirm specific requirements with the laboratory before booking.
Sample2 mL (1 mL minimum) serum from 1 Serum Separator Tube (SST).
MethodologyImmunofluorescence Assay (IFA).
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test detects IgA antibodies. Individuals with IgA deficiency may have false negative results. Results should be interpreted in the context of clinical presentation and other diagnostic tests.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Celiac disease is an autoimmune disorder where ingesting gluten leads to damage in the small intestine. It can cause various digestive and other symptoms.
Fasting ensures that food or drink does not interfere with the test results, providing a more accurate measurement of the antibodies.
A positive result indicates the presence of endomysial antibodies, which is often associated with celiac disease. Further evaluation by a healthcare provider is necessary.
Insurance coverage varies. Please check with your insurance provider regarding coverage for this specific test.
A blood sample is required for this test. It can be collected at one of our laboratory branches or through our home sample collection service.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp